ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,954.50
      1.59%
      US Tech 100
      20,332.80
      1.61%
      Dow Jones
      43,840.91
      1.39%
      Brent Oil
      73.045
      0.00%
      Bitcoin
      84,545.81
      0.21%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Innate Pharma (IPH) Quote

      Innate Pharma

      Innate Pharma (IPH)

      IPH Limited
      2.125
      -0.08
      (-3.63%)
      Closed March 01 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      2.125
      Bid
      2.11
      Ask
      2.15
      Volume
      163,878
      2.105 Day's Range 2.20
      1.332 52 Week Range 2.79
      Market Cap
      676.112M
      Previous Close
      2.205
      Open
      2.20
      Last Trade
      1
      @
      2.125
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      213,792
      Shares Outstanding
      318,170,508
      Dividend Yield
      -
      PE Ratio
      -89.08
      Earnings Per Share (EPS)
      -0.02
      Revenue
      61.64M
      Net Profit
      -7.57M

      About Innate Pharma

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.innate-pharma.com
      Headquarters
      Marseille, Bouches-du-rhone, Fra
      Founded
      -
      Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 2.21 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.79 €.

      Innate Pharma currently has 318,170,508 shares outstanding. The market capitalization of Innate Pharma is 701.57 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -89.08.

      Ask ADVFN Intelligence (AI)

      IPH Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.041.918465227822.0852.422.072610132.20651186DE
      40.39522.83236994221.732.51.732611602.09098199DE
      120.70549.64788732391.422.51.392137921.95201253DE
      260.0452.163461538462.082.51.3321333961.8917625DE
      52-0.275-11.45833333332.42.791.332980682.01443542DE
      156-0.857-28.73910127432.9823.81.3321320202.5611666DE
      260-4.075-65.72580645166.27.071.3322449313.68450046DE

      IPH - Frequently Asked Questions (FAQ)

      What is the current Innate Pharma share price?
      The current share price of Innate Pharma is 2.125 €
      How many Innate Pharma shares are in issue?
      Innate Pharma has 318,170,508 shares in issue
      What is the market cap of Innate Pharma?
      The market capitalisation of Innate Pharma is EUR 701.57M
      What is the 1 year trading range for Innate Pharma share price?
      Innate Pharma has traded in the range of 1.332 € to 2.79 € during the past year
      What is the PE ratio of Innate Pharma?
      The price to earnings ratio of Innate Pharma is -89.08
      What is the cash to sales ratio of Innate Pharma?
      The cash to sales ratio of Innate Pharma is 10.94
      What is the reporting currency for Innate Pharma?
      Innate Pharma reports financial results in EUR
      What is the latest annual turnover for Innate Pharma?
      The latest annual turnover of Innate Pharma is EUR 61.64M
      What is the latest annual profit for Innate Pharma?
      The latest annual profit of Innate Pharma is EUR -7.57M
      What is the registered address of Innate Pharma?
      The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009
      What is the Innate Pharma website address?
      The website address for Innate Pharma is www.innate-pharma.com
      Which industry sector does Innate Pharma operate in?
      Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALADOAdomos
      0.59 €
      (180.95%)
      		162.85k
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		24.87M
      DMSBSDiagnostic Medical Systems
      0.008 €
      (77.78%)
      		50k
      ALAMAAMA Corporation PLC
      0.233 €
      (29.81%)
      		847.73k
      LUDSLucibel DS
      0.0015 €
      (25.00%)
      		13.29k
      NEGDSNetmedia Group DS
      0.0001 €
      (-50.00%)
      		698
      ALPCVCerinnov Group
      0.618 €
      (-33.55%)
      		230.29k
      ALKALKALRAY SA
      0.641 €
      (-27.98%)
      		530.33k
      BPOSTBpost SA NV
      1.522 €
      (-26.83%)
      		6.5M
      FRVIAForvia SE
      8.442 €
      (-22.62%)
      		6.19M
      ATOAtos SE
      0.0032 €
      (0.00%)
      		472.41M
      BCPBanco Comercial Portugues SA
      0.5366 €
      (-4.89%)
      		135.45M
      BIOSBiosenic
      0.0029 €
      (-6.45%)
      		37.45M
      ALALOAcheterLouerFR
      0.0073 €
      (0.00%)
      		36.35M
      ALVERVergnet
      0.0004 €
      (0.00%)
      		33.19M

      Discussion

      View Full Feed
      Genz2 Genz2 1 minute ago
      https://www.theguardian.com/us-news/2025/feb/28/trump-russia-hacking-cyber-security

      I sure hope that the U.S. government and the critical industries are buying Wave’s security so our networks, data and devices are secure!! WWW - Win With Wave!!!!
      bas2020 bas2020 2 minutes ago
      I have this "theory" that someone will be called in under the law "suit." 👿☠️
      NWBO
      KngmAz KngmAz 2 minutes ago
      That was because she thinks that the stock price of HGRAF will soon be above $5.00 per share which it will be.
      HGRAF
      navycmdr navycmdr 2 minutes ago
      Senate floor vote ASAP so Bill Pulte can ASK for Fannie/Freddie UPLIST to NYSE

      https://investorshub.advfn.com/uimage/uploads/2025/3/1/hdwiyGSE.JPG
      FNMA
      surrealistrader surrealistrader 2 minutes ago
      Lest anyone forget the meteorite origin story!

      Study the fundamentals of legitimate mining stock investment. Accumulate comparables. Figure out how to look several steps ahead of managements alleged plans when it concerns developing and commercializing a mining project (you unfortunat
      SDRC
      BankingBig BankingBig 2 minutes ago
      I'm working on a DD package for BURU, if you have any info regarding HMBL or more specifically YBRA please tag me in your DD.
      I will post my completed findings on here as well
      BURU HMBL
      Humbert Humbert 3 minutes ago
      Companies like BNCM actually do wonders for the reputation of the Pink tier, which is filled to the brim with highly questionable operations. With Delex, you see a company using the OTC system in a responsible, dignified manner.
      BNCM
      Redoocs Redoocs 4 minutes ago
      I wanted a good laugh this morning, so before I head out the door to start my day I will start with you and work my way to the rest.

      No, I just piggybacked on my previous comment. No rhyme or reason for doing it. Hope you didn't lose any sleep over thinking it.
      oldmystic oldmystic 4 minutes ago
      The case for 25 by 05/25
      https://invst.ly/198-mo
      TLSA
      LVerstee LVerstee 4 minutes ago
      Uhg another classy email. Again it's interesting that you accuse me of criminal activity when your own criminal convictions are well-documented.
      ITUP
      Humbert Humbert 5 minutes ago
      Shelly would be wise to invest in what might be the best stock on the OTC.
      BNCM
      bas2020 bas2020 5 minutes ago
      Is this what the bosses are telling you?
      ...especially when it hits .23 next week.
      NWBO
      surfkast surfkast 6 minutes ago
      Very sujspicious and a paid promoter shows up!
      SPZI
      surfkast surfkast 7 minutes ago
      Don't you say to da moon all the time and usually fail? Look here, DILUTION! LOL. SMH!
      SMH
      prototype_101 prototype_101 8 minutes ago
      fear & greed game is what cause capitulations, when LWLG hit $20 I told everyone here it had gotten ahead of itself and was clearly a time to sell, and FACT is that I was the ONLY person to do that BTW, back then I used to post routinely that the fair value for Developments and IP to-date was in the
      LWLG
      prototype_101 prototype_101 9 minutes ago
      Gemini, when comparing the new materials, Polymers, TFLN and BTO for volume scaling modulators, which is the best and/or easiest solution for Next-gen Networks?

      Among the technologies you listed, Polymers are currently showing the most promising path toward volume scaling, particularl
      LWLG
      TenKay TenKay 9 minutes ago
      And yet they had ZERO revenue in the 3rd Quarter of 2024.
      HMBL
      learningcurve2020 learningcurve2020 10 minutes ago
      “celebrating NWBO's performance this week.” 🤣🤣🤣
      NWBO
      TenKay TenKay 10 minutes ago
      Yes about $40 worth of BURU stock for every MILLION shares of HMBL you own.

      But then there is also an equivalent amount of equity dilution going to BURU as Pref C…
      BURU HMBL
      jay_tee jay_tee 11 minutes ago
      I like how you put that IF in your post. Not too confident are you? If it doesn't positively impacts FOXO, it won't happen. Seamus has put all his eggs in FOXO. Can't count those chickens just yet. Again you do know I have shares right? Been stuck since 2023. If you win, I win. Smh
      FOXO
      DrSleep DrSleep 11 minutes ago
      Doesn’t it make sense to think that Hakim will get the best offer possible seeing as he has a HUGE shareholder percentage? I’m not the biggest stock guy but I would think he has the same mindset as we do. What am I missing? I’m gonna trust what he offers us.
      ELTP
      PennyMillions852 PennyMillions852 11 minutes ago
      Yep new 52 wk will happen!
      IGPK
      XMaster2023 XMaster2023 11 minutes ago
      Bas2020 I believe after Approval and a couple years of revenue NWBO will easily be worth 40 Billion. If Merck buys it, they will internalize the process to Keytruda, which will make Keytruda a better product but it will close out the rest of the market. This is not Linda Liau or Linda Powers goal.
      NWBO
      BBANBOB BBANBOB 11 minutes ago
      Bizreader
      Do you mind if I ask your age and educational degrees
      COOP

      Your Recent History

      EU
      IPH
      Innate Pharma
      BIT
      F22741
      Vontobel Financial Produ...
      BIT
      P19L34
      BNP Paribas Issuance
      BIT
      P1QA51
      BNP Paribas Issuance
      BIT
      I10415
      IT0005615502 20250620 43...
      BIT
      P1MG91
      BNP Paribas Issuance
      BIT
      P1PII5
      BNP Paribas Issuance
      BIT
      P1QS10
      BNP Paribas Issuance
      BIT
      I09554
      IT0005561706 20250915 28...
      BIT
      SESG
      Saturna Sustainable Esg ...
      BIT
      NSCIT2694866
      Agricultural Pension Bank
      AQSE
      FIND.GB
      WisdomTree Commodity Sec...
      BIT
      I07638
      Intesa Sanpaolo
      BIT
      F25752
      Vontobel Financial Produ...
      BIT
      S29810
      Societe Generale Effekten
      BIT
      UC59WX
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads